In this issue, we present another installment of our quarterly review of dealmaking—for October-December 2006. Our data comes from Windhover's Strategic Transactions Database, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics and research industries.
The pharmaceutical financing environment improved considerably for the final quarter of 2006, with nearly all areas of financing significantly outperforming those in the third quarter. The number of IPOs doubled...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?